首页> 美国卫生研究院文献>Journal of Assisted Reproduction and Genetics >Intracytoplasmic morphologically selected sperm injection (IMSI) does not improve outcome in patients with two successive IVF-ICSI failures
【2h】

Intracytoplasmic morphologically selected sperm injection (IMSI) does not improve outcome in patients with two successive IVF-ICSI failures

机译:两次连续IVF-ICSI衰竭患者的胞浆内形态选择精子注射(IMSI)不能改善预后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeAssessment of sperm morphology has been reconsidered since 2001 with the development of motile sperm organelle morphology examination (MSOME). This observation technique that combines high magnification microscopy and the Nomarski interference contrast makes it possible to select spermatozoa with as few vacuoles as possible before microinjection into the oocyte (intracytoplasmic morphologically selected sperm injection, IMSI). More than 10 years after the development of IMSI, the indications of the IMSI technique and its ability to increase pregnancy and/or birthrates (compared with conventional ICSI) are still subject to debate. We aimed to better define the interest of IMSI in the third attempt.
机译:目的自2001年以来,随着活动精子细胞器形态学检查(MSOME)的发展,重新考虑了精子形态的评估。这种观察技术结合了高倍镜和Nomarski干涉对比技术,可以在向卵母细胞显微注射之前(胞浆形态选择的精子注射,IMSI)选择液泡尽可能少的精子。 IMSI的发展已超过10年,但IMSI技术的适应症及其增加妊娠和/或出生率的能力(与传统的ICSI相比)仍存在争议。我们旨在在第三次尝试中更好地定义IMSI的兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号